News for Healthier Living
Roswell Park Team Discovers New Treatment Target for Neuroendocrine Prostate Cancer
A team of researchers at Roswell Park , led by Dhyan Chandra, PhD, has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat form of prostate cancer. Their findings, newly published in the journal Oncogene, suggest that a set of processes known as the mitochondrial unfolded protein response, could be an Achilles' heel for this often-deadly cancer type, and may point the way to a new treatment approach.
December 18, 2024
December 21 2024December 20 2024December 19 2024December 18 2024December 17 2024December 16 2024December 15 2024December 14 2024December 13 2024December 12 2024December 11 2024December 10 2024December 9 2024December 8 2024December 7 2024
|
|
|
|
|